- Dr. Ira-Ida Skvortsova
- Department of Therapeutic Radiology and Oncology, Innsbruck Medical University, Innsbruck, Austria.
Website | E-mail
Special Issue Introduction
It is generally believed that the small population of the intratumoral carcinoma stem cells (CSCs) is responsible for poor clinical outcome, because CSCs are considered as a reason for the tumor heterogeneity, diminished sensitivity to chemo- and radiotherapy and enhanced abilities for metastatic spread. Investigation of the biological properties of CSCs is a hot topic in cancer research. In order to know more about CSC behavior, it is necessary to possess the CSC-specific molecular patterns distinguishing CSCs from non-CSCs.
KeywordsCancer stem cells, treatment resistance, intracellular signaling, CSC markers, CSC phenotype
Submission Deadline17 Jun 2016